Ocular Therapeutix
OCUL
OCUL
108 hedge funds and large institutions have $301M invested in Ocular Therapeutix in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
8% less call options, than puts
Call options by funds: $1.84M | Put options by funds: $2.01M
6% less capital invested
Capital invested by funds: $321M → $301M (-$19.2M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
108
Holding in Top 10
5
Calls
$1.84M
Puts
$2.01M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$3.55M | |
| 3 | +$2.22M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.85M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.65M |
Top Sellers
| 1 | -$6M | |
| 2 | -$3.14M | |
| 3 | -$2.6M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.58M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.13M |